The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: clinical experience with anti-angiogenic agents, focusing on bevacizumab. (Q37131988)
Jump to navigation
Jump to search
scientific article published on 07 April 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: clinical experience with anti-angiogenic agents, focusing on bevacizumab. |
scientific article published on 07 April 2008 |
Statements
The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: clinical experience with anti-angiogenic agents, focusing on bevacizumab (English)